Videos | Bringing pharma’s top innovators to your screen

Oncology

ASCO 26: Three strong Pfizer Phase 3s, with Johanna Bendell

Pharmaphorum caught up with Johanna Bendell, Pfizer’s chief development officer for oncology, to learn about what the company is bringing to ASCO.

Oncology

Interview at ASCO 26 with David Spetzler

ASCO26: AI supercharging gene-based cancer detection, with D...

Pharmaphorum caught up with Caris Life Science's David Spetzler to talk about how agentic AI is empowering whole genome sequencing in cancer detection

R&D

Sponsored

IQVIA on reducing complexity and workload for clinical trial...

R&D

Sponsored

Rethinking clinical research: The case for human challenge t...

Digital

Interview at Reuters Pharma EU with Florian Schnappauf, Veeva

From data to deployment: Navigating AI adoption in pharma wi...

Explore our video interview for expert tips on AI adoption in pharma, featuring Veeva.

R&D

Sponsored

IQVIA on reducing complexity and workload for clinical trial...

R&D

Sponsored

Rethinking clinical research: The case for human challenge t...

Digital

From data to deployment: Navigating AI adoption in pharma wi...

Explore our video interview for expert tips on AI adoption in pharma, featuring Veeva.

Sales & Marketing

Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Sales & Marketing

Interview at JPM26 with Helen Sabzevari and Greg Skalicky

Rewiring commercialisation to meet the moment, with Helen Sa...

At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.

Digital

From data to deployment: Navigating AI adoption in pharma wi...

Explore our video interview for expert tips on AI adoption in pharma, featuring Veeva.

Digital

Inizio Ignite, STEM AI video feature image

Sponsored

STEM AI: Delivering intelligent data-led HCP interactions

In a new sponsored video, pharmaphorum spoke with experts from STEM, an Inizio Ignite company, about STEM AI

Market Access

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

Market Access

Interview with Marjorie Sidhoum at BIO Europe 2026

BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...

Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.

Oncology

ASCO 26: Three strong Pfizer Phase 3s, with Johanna Bendell

Pharmaphorum caught up with Johanna Bendell, Pfizer’s chief development officer for oncology, to learn about what the company is bringing to ASCO.

Oncology

ASCO26: AI supercharging gene-based cancer detection, with D...

Pharmaphorum caught up with Caris Life Science's David Spetzler to talk about how agentic AI is empowering whole genome sequencing in cancer detection

Oncology

LSX2026: Addressing adult eye cancer, with Roi Raz

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Patients

R&D

Sponsored

ASCO 26: Three strong Pfizer Phase 3s, with Johanna Bendell

ASCO26: AI supercharging gene-based cancer detection, with D...

IQVIA on reducing complexity and workload for clinical trial...

Rethinking clinical research: The case for human challenge t...

From data to deployment: Navigating AI adoption in pharma wi...

IQVIA on reducing complexity and workload for clinical trial...

Rethinking clinical research: The case for human challenge t...

From data to deployment: Navigating AI adoption in pharma wi...

Biotech is back, with Craig Ackerman

Rewiring commercialisation to meet the moment, with Helen Sa...

From data to deployment: Navigating AI adoption in pharma wi...

STEM AI: Delivering intelligent data-led HCP interactions

Making direct-to-patient work, with Matt Wadyka

BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...

ASCO 26: Three strong Pfizer Phase 3s, with Johanna Bendell

ASCO26: AI supercharging gene-based cancer detection, with D...

LSX2026: Addressing adult eye cancer, with Roi Raz

Making direct-to-patient work, with Matt Wadyka

LSX2026: On promise and patience, with Hans Schambye

Using patient data to fill in GLP-1 blind spots, with Phil J...

IQVIA on reducing complexity and workload for clinical trial...

Rethinking clinical research: The case for human challenge t...

LSX2026: Endogenous tissue restoration in vascular disease –...

ASCO 26: Three strong Pfizer Phase 3s, with Johanna Bendell

Discover a new era of healthcare panel engagement: Grounded ...

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks